共查询到20条相似文献,搜索用时 0 毫秒
1.
Toshiki Kaihara Takumi Higuma Masaki Izumo Nozomi Kotoku Tomomi Suzuki Haruka Kameshima Yukio Sato Shingo Kuwata Masashi Koga Takanobu Mitarai Mika Watanabe Kazuaki Okuyama Ryo Kamijima Yuki Ishibashi Kihei Yoneyama Yasuhiro Tanabe Tomoo Harada Yoshihiro J. Akashi 《Clinical cardiology》2021,44(8):1089
BackgroundA high frequency of coronary artery disease (CAD) is reported in patients with severe aortic valve stenosis (AS) who undergo transcatheter aortic valve implantation (TAVI). However, the optimal management of CAD in these patients remains unknown.HypothesisWe hypothesis that AS patients with TAVI complicated by CAD have poor prognosis. His study evaluates the prognoses of patients with CAD and severe AS after TAVI.MethodsWe divided 186 patients with severe AS undergoing TAVI into three groups: those with CAD involving the left main coronary (LM) or proximal left anterior descending artery (LAD) lesion (the CAD[LADp] group), those with CAD not involving the LM or a LAD proximal lesion (the CAD[non‐LADp] group), and those without CAD (Non‐CAD group). Clinical outcomes were compared among the three groups.ResultsThe CAD[LADp] group showed a higher incidence of major adverse cardiovascular and cerebrovascular events (MACCEs) and all‐cause mortality than the other two groups (log‐rank p = .001 and p = .008, respectively). Even after adjustment for STS score and percutaneous coronary intervention (PCI) before TAVI, CAD[LADp] remained associated with MACCE and all‐cause mortality. However, PCI for an LM or LAD proximal lesion pre‐TAVI did not reduce the risk of these outcomes.ConclusionsCAD with an LM or LAD proximal lesion is a strong independent predictor of mid‐term MACCEs and all‐cause mortality in patients with severe AS treated with TAVI. PCI before TAVI did not influence the outcomes. 相似文献
2.
3.
Impact of coronary artery disease on left ventricular ejection fraction recovery following transcatheter aortic valve implantation 下载免费PDF全文
Xavier Freixa MD Jason Chan MD Raoul Bonan MD Ragui Ibrahim MD Yoan Lamarche MD Philippe Demers MD Arsène Basmadjian MD Réda Ibrahim MD Raymond Cartier MD Anita W. Asgar MD 《Catheterization and cardiovascular interventions》2015,85(3):450-458
4.
5.
Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation 下载免费PDF全文
Dimitry Schewel MD Christian Frerker MD Jury Schewel MD Peter Wohlmuth PhD Felix Meincke MD Thomas Thielsen MD Felix Kreidel MD Karl‐Heinz Kuck MD Ulrich Schäfer MD 《Catheterization and cardiovascular interventions》2015,85(3):502-514
6.
Apostolos Tzikas MD Nicolo Piazza MD Bas M. van Dalen MD Carl Schultz MD PhD Marcel L. Geleijnse MD PhD Robert‐Jan van Geuns MD PhD Tjebbe W. Galema MD Rutger‐Jan Nuis MSc Amber Otten MSc Juan‐Luis Gutierrez‐Chico MD PhD Patrick W. Serruys MD PhD Peter P. de Jaegere MD PhD 《Catheterization and cardiovascular interventions》2010,75(1):43-49
Objectives : To assess the acute and intermediate changes in mitral regurgitation (MR) severity after transcatheter aortic valve implantation (TAVI) with the CoreValve Revalving SystemTM (CRS). Background : Following surgical aortic valve replacement, improvement in MR is reported in 27–82% of the patients. The changes in MR severity following CRS implantation are unknown. Methods : Transthoracic echocardiography was performed in 79 consecutive patients before and after treatment, and at the first outpatient visit. Left ventricular dimensions and ejection fraction (LVEF), left atrial (LA) size, and aortic gradient were measured. MR was assessed by color flow mapping and was graded as none, mild, moderate, or severe. It was defined as organic or functional. The depth of CRS implantation was measured by angiography. Results : Post‐treatment, the mean gradient decreased from 48 ± 16 mm Hg to 9 ± 5 mm Hg (P < 0.0001). There was no significant change in the left ventricular dimensions, LA size, and LVEF. MR pretreatment was mild, moderate, or severe in 57%, 18%, and 1% of the patients, respectively. It was defined as organic in 27 patients (36%) and functional in 27 patients (36%). The degree of MR remained unchanged in 61% of the patients, improved in 17%, and worsened in 22%. MR improvement was associated with a lower baseline LVEF (P = 0.02). There was no association between the changes in MR severity and the depth of CRS implantation. Conclusions : Most patients who underwent TAVI had some degree of MR. Overall there was no change in the degree of MR post‐treatment. Patients in whom MR improved had a lower LVEF at baseline. © 2009 Wiley‐Liss, Inc. 相似文献
7.
8.
Prevalence and predictors of carotid artery stenosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation 下载免费PDF全文
Arie Steinvil MD MHA Eran Leshem‐Rubinow MD MHA Yigal Abramowitz MD Yacov Shacham MD Yaron Arbel MD Shmuel Banai MD Natan M. Bornstein MD Ariel Finkelstein MD Amir Halkin MD 《Catheterization and cardiovascular interventions》2014,84(6):1007-1012
9.
10.
11.
Itsik Ben‐Dor MD Lowell F. Satler MD Augusto D. Pichard MD Ron Waksman MD 《Catheterization and cardiovascular interventions》2013,81(2):392-396
Transcatheter aortic valve implantation is a novel therapeutic approach for high‐risk patients with severe symptomatic aortic stenosis. The success rate of this new procedure is high; however, procedural complications can occur and may result in devastating outcomes. Here, we report a case of transfemoral catheter aortic valve implantation using the Edwards SAPIEN valve complicated by severe intravalvular leak due to immobile cusp associated with shock. We treated with a second valve that embolized and deployed in the descending aorta. A third valve was then deployed within the first with elimination of aortic regurgitation and immediate hemodynamic improvement. © 2012 Wiley Periodicals, Inc. 相似文献
12.
Impact of body mass index on the outcomes following transcatheter aortic valve implantation 下载免费PDF全文
Yigal Abramowitz MD Tarun Chakravarty MD Hasan Jilaihawi MD Justin Cox MD Rahul P. Sharma MD PhD Geeteshwar Mangat MD Mamoo Nakamura MD Wen Cheng MD Raj R. Makkar MD 《Catheterization and cardiovascular interventions》2016,88(1):127-134
13.
Concomitant coronary artery disease and its management in patients referred to transcatheter aortic valve implantation: Insights from the POL‐TAVI Registry 下载免费PDF全文
Zenon Huczek MD PhD Karol Zbroński MD Kajetan Grodecki Piotr Scisło MD PhD Bartosz Rymuza MD Janusz Kochman MD PhD Maciej Dąbrowski MD PhD Adam Witkowski MD PhD FESC Wojciech Wojakowski MD PhD FESC Radosław Parma MD PhD Andrzej Ochała MD PhD FESC Marek Grygier MD PhD Anna Olasińska‐Wiśniewska MD PhD Aleksander Araszkiewicz MD PhD Dariusz Jagielak MD PhD Dariusz Ciećwierz MD PhD Dominika Puchta MD Katarzyna Paczwa Krzysztof J. Filipiak MD PhD FESC Radosław Wilimski MD Marian Zembala MD PhD FESC Grzegorz Opolski MD PhD FESC 《Catheterization and cardiovascular interventions》2018,91(1):115-123
- The femoropopliteal (FP) artery is a common site for endovascular interventions.
- S.M.A.R.T.® stent is effective in treating FP lesions with results comparable to other treatment options.
- Without head‐to‐head randomized controlled trials, the ideal treatment strategy for FP lesions remains unknown.
14.
Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self‐expandable bioprosthetic valve 下载免费PDF全文
Wah Wah Htun MD FACC Cindy Grines MD FACC FSCAI Theodore Schreiber MD FACC FSCAI 《Catheterization and cardiovascular interventions》2018,91(7):1339-1344
15.
Jun Li Sandeep M. Patel Fahd Nadeem Prashanth Thakker Sadeer Al‐Kindi Rahul Thomas Amber Makani John M. Hornick Toral Patel Jerry Lipinski Yasuhiro Ichibori Angela Davis Alan H. Markowitz Hiram G. Bezerra Daniel I. Simon Marco A. Costa Ankur Kalra Guilherme F. Attizzani 《Catheterization and cardiovascular interventions》2019,93(3):545-552
16.
Ehud Jacobzon Arik Wolak Danny Fink Shuli Silberman 《Catheterization and cardiovascular interventions》2019,93(7):E391-E393
We report a case of a 78‐year‐old female who presented with type A aortic dissection 22 months following transcatheter aortic valve implantation (TAVI). In addition, preoperative echocardiogram showed high gradients across the aortic prosthesis which was found to be thrombosed. At surgery, the intimal tear appeared to be non‐acute and anatomically related to the rim of the valve cage. The thrombosed valve was not replaced and the patient received anticoagulation therapy following surgery with significant improvement in valve gradients. 相似文献
17.
Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world 下载免费PDF全文
Takahide Arai MD Thierry Lefèvre MD FESC FSCAI Thomas Hovasse MD Philippe Garot MD Hakim Benamer MD Thierry Unterseeh MD Andrew K. Roy MD Mauro Romano MD Kentaro Hayashida MD PhD FESC Yusuke Watanabe MD Erik Bouvier MD Marie‐Claude Morice MD FESC FACC Bernard Chevalier MD FESC FSCAI 《Catheterization and cardiovascular interventions》2017,90(7):1192-1197
18.
Access closure is a key element to successful retrograde percutaneous transfemoral transcatheter aortic valve implantation. It requires large-bore femoral arterial access (18Fr-28Fr) which most operators manage with surgical access and closure under general anesthesia. We report a case example of how, using our center's peripheral interventional experience, we have developed a simple five step technique to achieve hemostasis percutaneously. 相似文献
19.
Nicolo Piazza MD Patrick W. Serruys MD PhD Peter de Jaegere MD PhD 《Catheterization and cardiovascular interventions》2009,73(2):161-166
Coronary atherosclerosis is a common finding in patients with severe aortic stenosis. Indeed, aortic stenosis is associated with risk factors similar those of coronary atherosclerosis such as older age, hypertension, diabetes, hypercholesterolemia and smoking. In light of the evolution of percutaneous aortic valve implantation (PAVI) and ongoing improvements in techniques of PCI, a combined approach using PCI and PAVI can be proposed for patients with complex coronary artery and aortic valve disease. This report describes the feasibility of the combination of percutaneous coronary intervention and percutaneous aortic valve implantation with peripheral left ventricular assist device (TandemHeart) support in 3 elderly patients with complex coronary altery disease and aortic stenosis considered too high risk for conventional surgical therapy. © 2009 Wiley‐Liss, Inc. 相似文献
20.
Kentaro Mitsui MD Kensuke Takagi MD PhD Takashi Kakuta MD Teruo Noguchi MD PhD 《Catheterization and cardiovascular interventions》2023,102(7):1259-1262
Valve-in-valve transcatheter aortic valve replacement (valve-in-valve TAVR) increases the risk of coronary obstruction. Although the coronary protection strategy is widely used, the use of the bailout technique after coronary obstruction is limited. Hence, we report a simple bailout technique for coronary obstruction after valve-in-valve TAVR. An 82-year-old woman presented with structural valve deterioration. The left anterior descending coronary artery had 90% stenosis. After TAVR, the prosthetic valve shifted close to the ascending aorta wall, consequently impairing coronary flow. The wire crossed with the Judkins right guiding catheter (JR) reference to the en-face and perpendicular views. Using the guide-extension catheter, the JR contacted the contralateral ascending aorta as a backup catheter. After a balloon was dilated between the prosthetic valve and aorta, JR engaged into the coronary artery with excellent backup. This novel “Whisker pole guiding technique” is useful, even after valve-in-valve TAVR. 相似文献